Progression-free Survival Clinical Trials

29 clinical trials for Progression-free Survival across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Long-term Follow-up of Subjects Treated With CAR T Cells — RECRUITING
• Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy — RECRUITING · PHASE2
• Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer — RECRUITING · PHASE3
• A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial — RECRUITING · NA
• Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors — RECRUITING · PHASE2
• Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma — NOT_YET_RECRUITING · NA
• Safety and Efficacy Analysis of Oral Etoposide Combined With Anlotinib and Envafolimab in First-line Treatment of Elderly Patients With Small Cell Lung Cancer/ Open-label, Single-arm, Exploratory Phase II Clinical Study — ACTIVE_NOT_RECRUITING · PHASE2
• Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer — ACTIVE_NOT_RECRUITING
• Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma. — OTHER · NA
• Advanced Pancreatic Cancer — OTHER · PHASE2
• Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line Treatment — OTHER · PHASE4
• Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma — COMPLETED · NA
• Real-world Study for Patients With Advanced Hepatobiliary Tumors — OTHER
• Maintenance Therapy for Small-cell Lung Cancer — COMPLETED · PHASE2
• PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer — OTHER
• HRD and Resistance to PAPPi in EOC Patients — OTHER
• Chromosomal Instability in Ovarian Cancer — OTHER
• IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer — OTHER · PHASE2
• Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma — OTHER · PHASE2
• Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma — COMPLETED · PHASE2
• Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma — WITHDRAWN · PHASE2
• Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total Resection — NOT_YET_RECRUITING · NA
• Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer — OTHER · PHASE3
• A Genomic Analysis of Evolution of Epithelia Ovarian Tumors — OTHER
• Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer — COMPLETED · PHASE2
• Clinical Study on Triple Negative Breast Cancer With Chinese Medicine — OTHER
• A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer — OTHER · PHASE3
• Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients — COMPLETED · PHASE2
• Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI) — COMPLETED · PHASE3

Refine this search